结肠镜阴性者上消化道癌症发生率低,与多靶点粪便DNA检测结果无关
该回顾性队列研究纳入1216例结肠镜筛查无肿瘤或仅非进展期腺瘤者,比较多靶点粪便DNA检测一致阴性组(n=1011)与不一致阳性组(n=205)的上消化道癌症发生率。结论认为结肠镜阴性者上消化道癌症不常见。
要点
- 结肠镜阴性者上消化道癌症发生率低,与粪便DNA检测结果无关。
- 一致阴性组上消化道癌症发生率低于SEER预期(RR 0.4)。
核心结论
- 结肠镜筛查阴性者上消化道癌症发生率低,无论多靶点粪便DNA检测结果一致或不一致。
- 高质量结肠镜阴性者不应进一步检测。
研究设计与样本
- 回顾性队列研究,纳入北美3个医疗中心1216例有完整病历和/或癌症登记数据者。
- 受试者基于筛查结肠镜无肿瘤或仅非进展期腺瘤,粪便DNA检测阴性组1011例,阳性组205例。
主要发现
- 中位随访时间:不一致组5.3年(IQR 3.5-5.8),一致组5.4年(IQR 3.7-5.8)。
临床怎么用
- 结肠镜筛查阴性者上消化道癌症不常见,不应基于粪便DNA检测结果进一步检测。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We aimed to compare the incidence of aerodigestive cancers in persons with negative results from colonoscopies and positive vs negative results from multitarget stool DNA tests for colorectal cancer and vs expected incidence. METHODS: We performed a retrospective cohort study of 1216 subjects with comprehensive patient records and/or cancer registry data from 3 medical centers in North America. Subjects had no neoplasia or only nonadvanced adenomas, based on screening colonoscopy, and either negative results (concordant with colonoscopy, n = 1011) or positive results (discordant colonoscopy, n = 205) from the multitarget stool DNA test. Outcomes included aerodigestive cancers in discordant vs concordant groups and comparison of observed aerodigestive cancer incidence between the groups and compared with expected incidence for the population, based on the Surveillance, Epidemiology, and End Results (SEER) data. RESULTS: Median follow-up times were comparable between subjects in the discordant (5.3 y; interquartile range, 3.5-5.8 y) and concordant (5.4 y; interquartile range, 3.7-5.8 y) groups. Aerodigestive cancers developed in 5 subjects in the discordant group vs 11 subjects in the concordant group (crude risk ratio, 2.3; 95% CI, 0.8-6.6; adjusted risk ratio, 2.2; 95% CI, 0.8-6.2; P = .151). The incidence of aerodigestive cancer was lower in the concordant group than the expected incidence based on SEER data (risk ratio, 0.4; 95% CI, 0.2-0.6; P = .0008). The incidence of aerodigestive cancer was not significantly greater in the population in the discordant group than the expected incidence based on SEER data (risk ratio, 0.8; 95% CI, 0.3-1.9; P = .599). CONCLUSIONS: In a retrospective study with a median follow-up time of 5.4 years, incident aerodigestive cancers were uncommon among subjects with negative findings from colonoscopies, regardless of discordant or concordant results from multitarget stool DNA tests. Patients with negative results from high-quality colonoscopies therefore should not undergo further testing.
引用
- Berger BM, Kisiel JB, Imperiale TF, et al. Low Incidence of Aerodigestive Cancers in Patients With Negative Results From Colonoscopies, Regardless of Findings From Multitarget Stool DNA Tests. Clin Gastroenterol Hepatol. 2019. PMID: 31394289. doi:10.1016/j.cgh.2019.07.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。